Loading clinical trials...
Loading clinical trials...
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetes With Inadequate Glycemic Control on Insulin Therapy Alone or Insulin Therapy Combination With Other Oral Anti-diabetic Agents
The purpose of the study is to see how safe and effective and tolerable the use of WelChol® is for type 2 diabetes when added to insulin alone or in combination with other anti-diabetic drugs
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
Tuscumbia, Alabama, United States
Sierra Vista, Arizona, United States
Jonesboro, Arkansas, United States
Searcy, Arkansas, United States
Carmichael, California, United States
Concord, California, United States
Fullerton, California, United States
La Jolla, California, United States
San Diego, California, United States
West Hills, California, United States
Start Date
June 1, 2004
Primary Completion Date
December 1, 2005
Completion Date
December 1, 2005
Last Updated
January 18, 2012
260
Estimated participants
Colesevelam hydrochloride
DRUG
Lead Sponsor
Daiichi Sankyo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06671587